Testicular, Penile, and Rare Malignancies

Open Versus Robotic RPLND in Clinical Stage 2 Testicular Cancer
Robotic primary retroperitoneal lymph node dissection (R-RPLND) may offer lower morbidity and improved perioperative outcomes than open RPLND (O-RPLND) for patients with clinical stage 2 (CS II) testicular cancer, according to new research presented at the 24th Annual Meeting of the Society of Urologic Oncology. O-RPLND is considered by many to be the gold standard for primary dissection of the retroperitoneal lymph nodes, though an increased utilization of R-RPLND has been observed in recent years because of its potential for lower blood loss, shorter hospital length of stay (LOS), faster recovery, and superior cosmetic results. A comparison of ...
Advertisement

Latest News

Advertisement

Knowledge Hub Spotlights

Curated clinical content based on conditions, therapies, and technologies

Prostate Cancer
Prostate Cancer

Conference Coverage

Advertisement
Advertisement
Trending